Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction
NCT ID: NCT01593566
Last Updated: 2015-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2011-04-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction
NCT00175630
Femoral Triangle + IPACK Blocks for ACL Reconstruction Analgesia
NCT05068063
Femoral Nerve Block Versus Adductor Canal Nerve Block for Peri-Operative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction: Evaluation of Post-operative Pain and Strength
NCT03033589
USG Nerve Blocks for ACL Reconstruction
NCT01840800
Adductor Canal Block In Anterior Cruciate Ligament (ACL) Repair
NCT01791036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0.25% bupivacaine
femoral nerve block using 0.25% bupivacaine versus 0.5% bupivacaine
0.25% Bupivacaine
Femoral nerve block using 0.25% versus 0.5% bupivacaine
0.5% bupivacaine
femoral nerve block using 0.25% bupivacaine versus 0.5% bupivacaine
0.5% Bupivacaine
Femoral nerve block using 0.25% versus 0.5% bupivacaine for analgesia after ACL reconstruction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.25% Bupivacaine
Femoral nerve block using 0.25% versus 0.5% bupivacaine
0.5% Bupivacaine
Femoral nerve block using 0.25% versus 0.5% bupivacaine for analgesia after ACL reconstruction
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status I-II
* Body weight \> or = 50 kg.
Exclusion Criteria
* Contraindication to neuraxial block
* allergy to local anesthetics, sulfa, NSAIDs, morphine, paracetamol
* Patients with communication problem
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
arissara iamaroon
associated professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
arissara iamaroon
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mahidol University
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.